160 related articles for article (PubMed ID: 32943587)
1. Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.
Ahmadpour D; Ahmadpoor P; Rostaing L
Iran J Kidney Dis; 2020 Sep; 14(5):331-334. PubMed ID: 32943587
[TBL] [Abstract][Full Text] [Related]
2. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
3. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
Omotuyi IO; Nash O; Ajiboye OB; Iwegbulam CG; Oyinloye EB; Oyedeji OA; Kashim ZA; Okaiyeto K
J Comput Chem; 2020 Sep; 41(24):2158-2161. PubMed ID: 32779780
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
5. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
6. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
7. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
8. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
Yurkovetskiy L; Wang X; Pascal KE; Tomkins-Tinch C; Nyalile TP; Wang Y; Baum A; Diehl WE; Dauphin A; Carbone C; Veinotte K; Egri SB; Schaffner SF; Lemieux JE; Munro JB; Rafique A; Barve A; Sabeti PC; Kyratsous CA; Dudkina NV; Shen K; Luban J
Cell; 2020 Oct; 183(3):739-751.e8. PubMed ID: 32991842
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
Mittal A; Manjunath K; Ranjan RK; Kaushik S; Kumar S; Verma V
PLoS Pathog; 2020 Aug; 16(8):e1008762. PubMed ID: 32822426
[TBL] [Abstract][Full Text] [Related]
10. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
12. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
[TBL] [Abstract][Full Text] [Related]
13. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
Zhang S; Liu Y; Wang X; Yang L; Li H; Wang Y; Liu M; Zhao X; Xie Y; Yang Y; Zhang S; Fan Z; Dong J; Yuan Z; Ding Z; Zhang Y; Hu L
J Hematol Oncol; 2020 Sep; 13(1):120. PubMed ID: 32887634
[TBL] [Abstract][Full Text] [Related]
15. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
16. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
18. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
Choudhary S; Malik YS; Tomar S
Front Immunol; 2020; 11():1664. PubMed ID: 32754161
[TBL] [Abstract][Full Text] [Related]
19. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
Huang SY; Kung YA; Huang PN; Chang SY; Gong YN; Han YJ; Chiang HJ; Liu KT; Lee KM; Chang CY; Chang CC; Huang CG; Shih SR
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789940
[TBL] [Abstract][Full Text] [Related]
20.
Br B; Damle H; Ganju S; Damle L
F1000Res; 2020; 9():663. PubMed ID: 32765844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
